Alzamend Neuro (ALZN) Insider Trading & Ownership $3.53 +0.36 (+11.36%) Closing price 04:00 PM EasternExtended Trading$3.50 -0.02 (-0.71%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alzamend Neuro (NASDAQ:ALZN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.21%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$13.32KNumber OfInsiders Selling(Last 12 Months)0 Get ALZN Insider Trade Alerts Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALZN Insider Buying and Selling by Quarter Alzamend Neuro Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/26/2025William B HorneDirectorBuy370$8.91$3,296.70 3/20/2025William B HorneDirectorBuy555$8.82$4,895.10 3/18/2025Milton C Ault IIIDirectorBuy555$8.64$4,795.20 3/12/2025Milton C Ault IIIDirectorBuy11$6.12$67.32 8/6/2024Milton C Ault IIIDirectorBuy8$24.75$198.00 7/31/2024Milton C Ault IIIDirectorBuy2$33.66$67.32 (Data available from 1/1/2013 forward) ALZN Insider Trading Activity - Frequently Asked Questions Who is on Alzamend Neuro's Insider Roster? The list of insiders at Alzamend Neuro includes David J Katzoff, Lynne Fahey Mcgrath, Milton C Ault III, Stephan Jackman, and William B Horne. Learn more on insiders at ALZN. What percentage of Alzamend Neuro stock is owned by insiders? 30.21% of Alzamend Neuro stock is owned by insiders. Learn more on ALZN's insider holdings. Which Alzamend Neuro insiders have been buying company stock? The following insiders have purchased ALZN shares in the last 24 months: David J Katzoff ($10,003.50), Milton C Ault III ($11,676.24), and William B Horne ($8,191.80). How much insider buying is happening at Alzamend Neuro? Insiders have purchased a total of 1,616 ALZN shares in the last 24 months for a total of $29,871.54 bought. Alzamend Neuro Key ExecutivesMr. Stephan Jackman (Age 47)CEO & Director Compensation: $434.24kMr. David J. Katzoff (Age 61)Chief Financial Officer Compensation: $116.67kMr. Milton Charles Ault III (Age 54)Founder & Vice Chairman Mr. Henry C. W. Nisser Esq. (Age 55)Executive VP, General Counsel & Director Compensation: $50kMr. Kenneth S. Cragun CPA (Age 63)Senior Vice President of Finance More Insider Trading Tools from MarketBeat Related Companies AEON Biopharma Insider Trading GeoVax Labs Insider Trading Cellectar Biosciences Insider Trading Chromocell Therapeutics Insider Trading Kiora Pharmaceuticals Insider Trading Biomerica Insider Trading Turnstone Biologics Insider Trading Alaunos Therapeutics Insider Trading GENPREX Insider Trading Lixte Biotechnology Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:ALZN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALZN Stock Alerts